報價延遲最少15分鐘:2024/12/23 22:19 EST
|
|
|
|
|
||||||||||||
|
|
|
|
|
45.56 
|
|
|
| 價值評估 |
|
盈利(現時/預測)
-5.94/2.56
|
|
企業價值
5.59B
|
| 資產負債 |
|
每股賬面淨值
-13.67
|
| 現金流量 |
|
現金流量率
--
|
| 損益表 |
|
收益
937.82M
|
|
每股收益
10.35
|
|
同行比較
|
||||||||||||||||||||||||||||||||||||||||||||||||
|
報價延遲最少15分鐘：2024/12/23 22:19 EST
同行比較之報價最少15分鐘延遲
|
業務概覽
|
|||
| PTC Therapeutics Inc is a biopharmaceutical company focused on the discovery, development, and commercialization of orally administered, small-molecule therapeutics. Its target area is RNA biology post-transcriptional control processes of the events occurring in a cell when an RNA messenger is copied from DNA during the transcription process. The discovered products address multiple therapeutic areas, including rare disorders, such as nonsense mutations in Duchenne muscular dystrophy and oncology. |